{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:43:04Z","timestamp":1795110184210,"version":"4.10.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.cmet.2020.07.002","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T10:46:26Z","timestamp":1595933186000},"page":"353-365.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action"],"prefix":"10.1016","volume":"32","author":[{"given":"Lance A.","family":"Thielen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Moukha-Chafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeongHo","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truman B.","family":"Grayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne E.","family":"Augelli-Szafran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Suto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Kanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Sethupathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anath","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2020.07.002_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/endo.130.1.1370150","article-title":"Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines","volume":"130","author":"Asfari","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2020.07.002_bib2","doi-asserted-by":"crossref","first-page":"16898","DOI":"10.1074\/jbc.M109.010504","article-title":"Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells","volume":"284","author":"Cha-Molstad","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2020.07.002_bib3","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1096\/fj.08-111690","article-title":"Thioredoxin-interacting protein deficiency induces Akt\/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes","volume":"22","author":"Chen","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.cmet.2020.07.002_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/db07-0715","article-title":"Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis","volume":"57","author":"Chen","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2020.07.002_bib5","doi-asserted-by":"crossref","first-page":"H64","DOI":"10.1152\/ajpheart.00151.2016","article-title":"TXNIP regulates myocardial fatty acid oxidation via miR-33a signaling","volume":"311","author":"Chen","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cmet.2020.07.002_bib6","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1074\/jbc.M708169200","article-title":"Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production","volume":"283","author":"Chutkow","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2020.07.002_bib7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.amjcard.2006.04.030","article-title":"Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST])","volume":"98","author":"Cooper-Dehoff","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cmet.2020.07.002_bib8","first-page":"2813489","article-title":"Early Treatment with Empagliflozin and GABA Improves \u03b2-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice","volume":"2019","author":"Daems","year":"2019","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.cmet.2020.07.002_bib9","doi-asserted-by":"crossref","first-page":"e3155","DOI":"10.7717\/peerj.3155","article-title":"Metformin ameliorates insulitis in STZ-induced diabetic mice","volume":"5","author":"Han","year":"2017","journal-title":"PeerJ"},{"key":"10.1016\/j.cmet.2020.07.002_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4161\/isl.2.6.13858","article-title":"A role for islet somatostatin in mediating sympathetic regulation of glucagon secretion","volume":"2","author":"Hauge-Evans","year":"2010","journal-title":"Islets"},{"key":"10.1016\/j.cmet.2020.07.002_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/db17-0506","article-title":"miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function","volume":"67","author":"Jo","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2020.07.002_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diabres.2016.01.021","article-title":"Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study","volume":"115","author":"Khodneva","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cmet.2020.07.002_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-59745-448-3_15","article-title":"Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in\u00a0vivo","volume":"560","author":"Kim","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cmet.2020.07.002_bib14","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2337\/db18-0068","article-title":"Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents","volume":"67","author":"Kim","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2020.07.002_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cmet.2012.07.007","article-title":"IRE1\u03b1 induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress","volume":"16","author":"Lerner","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2020.07.002_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2337\/diabetes.53.2.410","article-title":"Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db\/db mice","volume":"53","author":"Liang","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2020.07.002_bib17","doi-asserted-by":"crossref","first-page":"e2983","DOI":"10.1002\/dmrr.2983","article-title":"Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials","volume":"34","author":"Meng","year":"2018","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cmet.2020.07.002_bib18","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1210\/en.2004-1378","article-title":"Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis","volume":"146","author":"Minn","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2020.07.002_bib19","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1073\/pnas.1715930115","article-title":"Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action","volume":"115","author":"Nagaraj","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2020.07.002_bib20","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","article-title":"Verapamil and beta cell function in adults with recent-onset type 1 diabetes","volume":"24","author":"Ovalle","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2020.07.002_bib21","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1038\/cddis.2010.42","article-title":"Inhibition of TXNIP expression in\u00a0vivo blocks early pathologies of diabetic retinopathy","volume":"1","author":"Perrone","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cmet.2020.07.002_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/endo.143.2.8623","article-title":"Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity","volume":"143","author":"Poitout","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2020.07.002_bib23","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2337\/db14-1195","article-title":"Connective tissue growth factor modulates adult \u03b2-cell maturity and proliferation to promote \u03b2-cell regeneration in mice","volume":"64","author":"Riley","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2020.07.002_bib24","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1074\/jbc.M109.034421","article-title":"Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein","volume":"285","author":"Saxena","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2020.07.002_bib25","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1080\/13543784.2017.1395020","article-title":"Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes","volume":"26","author":"Scheen","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.cmet.2020.07.002_bib26","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1681\/ASN.2014050528","article-title":"Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy","volume":"26","author":"Shah","year":"2015","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.cmet.2020.07.002_bib27","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1210\/en.2002-220564","article-title":"Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway","volume":"143","author":"Shalev","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2020.07.002_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cell.2017.03.001","article-title":"Selective Chemical Inhibition of PGC-1alpha Gluconeogenic Activity Ameliorates Type 2 Diabetes","volume":"169","author":"Sharabi","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2020.07.002_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(19)30154-8","article-title":"SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks","volume":"7","author":"Taylor","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cmet.2020.07.002_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(75)92375-2","article-title":"The essential role of glucagon in the pathogenesis of diabetes mellitus","volume":"1","author":"Unger","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2020.07.002_bib31","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41374-018-0078-8","article-title":"Thioredoxin-interacting protein deficiency ameliorates kidney inflammation and fibrosis in mice with unilateral ureteral obstruction","volume":"98","author":"Wu","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.cmet.2020.07.002_bib32","doi-asserted-by":"crossref","first-page":"39394","DOI":"10.1074\/jbc.M502966200","article-title":"Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia","volume":"280","author":"Xiang","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2020.07.002_bib33","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/db11-0955","article-title":"Preventing \u03b2-cell loss and diabetes with calcium channel blockers","volume":"61","author":"Xu","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2020.07.002_bib34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/nm.3287","article-title":"Thioredoxin-interacting protein regulates insulin transcription through microRNA-204","volume":"19","author":"Xu","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2020.07.002_bib35","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1210\/jc.2016-3778","article-title":"Verapamil Use Is Associated With Reduction of Newly Diagnosed Diabetes Mellitus","volume":"102","author":"Yin","year":"2017","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2020.07.002_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1172\/JCI44927","article-title":"Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury","volume":"122","author":"Yoshioka","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cmet.2020.07.002_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat. Immunol."}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413120303600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413120303600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:34:18Z","timestamp":1761550458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413120303600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1550413120303600"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2020.07.002","relation":{},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2020.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}